SOX5 and ovarian carcinoma: The SOX5-High group exhibited shorter OS than the SOX5-Low group in five of seven data sets of ovarian cancer patients (Fig. 7A–E), although GSE18520 and GSE9891 analyses did not support our data (data not shown).